分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Spinal cord tissue engineering using human primary neural progenitor cells and astrocytes

Chen Jin, Yayu Wu, Haipeng Zhang, Bai Xu, Wenbin Liu, Chunnan Ji, Panpan Li, Zhenni Chen, Bing Chen, Jiayin Li, Xianming Wu, Peipei Jiang, Yali Hu, Zhifeng Xiao, Yannan Zhao, Jianwu Dai

Journal:Bioengineering & Translational Medicine

IF:10.68

DOI:10.1002/btm2.10448

PMID:36925694

Published:2022-11-09

research field:神经科学再生医学组织工程

Abstract

Neural progenitor cell (NPC) transplantation is a promising approach for repairing spinal cord injury (SCI). However, cell survival, maturation and integration after transplantation are still major challenges. Here, we produced a novel centimeter-scale human spinal cord neural tissue (hscNT) construct with human spinal cord neural progenitor cells (hscNPCs) and human spinal cord astrocytes (hscAS) on a linearly ordered collagen scaffold (LOCS). The hscAS promoted hscNPC adhesion, survival and neurite outgrowth on the LOCS, to form a linearly ordered spinal cord-like structure consisting of mature neurons and glia cells. When transplanted into rats with SCI, the hscNT created a favorable microenvironment by inhibiting inflammation and glial scar formation, and promoted neural and vascular regeneration. Notably, the hscNT promoted neural circuit reconstruction and motor functional recovery. Engineered human spinal cord implants containing astrocytes and neurons assembled on axon guidance scaffolds may therefore have potential in the treatment of SCI.

本文使用的Yeasen产品

购物车
客服
转染试用